Gotenba, Japan

Teruo Nakamura


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Shizuoka, JP (2011 - 2012)
  • Gotenba, JP (2010 - 2016)
  • Gotemba, JP (2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Teruo Nakamura

Introduction: Teruo Nakamura, an accomplished inventor based in Gotenba, Japan, has made significant strides in the field of biochemistry through his innovative work on hyaluronic acid derivatives. With a total of seven patents to his name, Nakamura exemplifies the spirit of creativity and advancement in modern science.

Latest Patents: Among Nakamura's latest inventions are two noteworthy patents focused on hyaluronic acid derivatives. The first patent presents a modification of hyaluronic acid with polyethylene glycol, introducing specific cationic, hydrophobic, and hydrophilic sites. This advancement allows for the creation of drug complexes and pharmaceutical compositions that include these derivatives, enhancing their therapeutic potential. The second patent involves the introduction of cationic and hydrophobic groups into hyaluronic acid derivatives, expanding the application of these innovative compounds.

Career Highlights: Teruo Nakamura is affiliated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His dedication to research and development at the company has allowed him to contribute valuable intellectual property to the pharmaceutical field, particularly in drug delivery systems.

Collaborations: Throughout his career, Nakamura has worked alongside esteemed colleagues such as Tsuyoshi Shimoboji and Kenji Yasugi. Their collaborative efforts have fostered an environment of innovation and have contributed to the successful development of new products and research initiatives.

Conclusion: Teruo Nakamura's impactful work in the field of hyaluronic acid derivatives demonstrates his commitment to advancing medical science. With a portfolio of seven patents and a collaborative spirit, he continues to pave the way for future innovations in drug formulation and delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…